Common Stock
Quick-Med begins trading
Published in Medical Devices and Surgical Technology Week, October 20th, 2002
Quick-Med Technologies (QMT) is a biotech/medical device company developing advanced technologies that QMT believes will fundamentally change several key product markets.
The company will initially focus on commercializing two core technologies: its Matrix Metalloproteinase Inhibitor technology (ilomastat) and an advanced polymer with properties that include super absorbency, hemostasis, and a high-level of antimicrobial efficacy.
QMT will develop ilomastat in several key markets including wound...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Biliary Obstructions
Nitinol-based, self-expanding, crush-recoverable stent introduced - Orthopedic Rehabilitation
HelpMate Robotics provides key highlights - Bone Grafts
Growing acceptance of orthobiologics spurs rapidly expanding U.S. markets - HIV Diagnostics
Calypte to accelerate development of rapid HIV urine test - Heart Failure
Access CardioSystems receives FDA clearance for external defibrillators - Restenosis
EuroSPAH intravascular sonotherapy trial results presented at society meeting - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
